• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical benefit of treatment for metastatic renal cell cancer at high volume facilities.

作者信息

Haque Waqar, Aghazadeh Monty, Miles Brian J, Satkunasivam Raj, Butler E Brian, Teh Bin S

机构信息

Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA.

Department of Urology, Houston Methodist Hospital, Houston, TX, USA.

出版信息

Ann Transl Med. 2018 Dec;6(Suppl 2):S90. doi: 10.21037/atm.2018.11.02.

DOI:10.21037/atm.2018.11.02
PMID:30740411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6330623/
Abstract
摘要

相似文献

1
Clinical benefit of treatment for metastatic renal cell cancer at high volume facilities.大型医疗机构对转移性肾细胞癌的治疗临床获益
Ann Transl Med. 2018 Dec;6(Suppl 2):S90. doi: 10.21037/atm.2018.11.02.
2
The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.靶向治疗时代转移性肾细胞癌患者的医疗机构病例数量与总生存期之间的关联。
Urol Oncol. 2018 Oct;36(10):470.e19-470.e29. doi: 10.1016/j.urolonc.2018.06.013. Epub 2018 Aug 18.
3
Clinical characteristics and treatment-related biomarkers associated with response to high-dose interleukin-2 in metastatic melanoma and renal cell carcinoma: retrospective analysis of an academic community hospital's experience.转移性黑色素瘤和肾细胞癌中与高剂量白细胞介素-2反应相关的临床特征及治疗相关生物标志物：一所学术社区医院经验的回顾性分析
Springerplus. 2015 Mar 7;4:118. doi: 10.1186/s40064-015-0890-1. eCollection 2015.
4
Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer.医院容量与转移性非小细胞肺癌患者死亡率之间的关联。
Lung Cancer. 2018 Aug;122:214-219. doi: 10.1016/j.lungcan.2018.06.025. Epub 2018 Jun 19.
5
Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies.转移性去势初治前列腺癌患者的负担，以识别更可能从早期多西他赛治疗中获益的男性：CHAARTED和GETUG-AFU15研究的进一步分析
Eur Urol. 2018 Jun;73(6):847-855. doi: 10.1016/j.eururo.2018.02.001. Epub 2018 Feb 21.
6
Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib.舒尼替尼治疗转移性肾嫌色细胞癌患者的疗效
Oncologist. 2016 Oct;21(10):1212-1217. doi: 10.1634/theoncologist.2015-0428. Epub 2016 Jul 5.
7
Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.无腹膜后淋巴结肿大可预测转移性肾细胞癌患者的生存情况。
J Urol. 2001 Jul;166(1):68-72.
8
Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer.生存率的提高与晚期喉癌患者在大容量教学医院接受治疗有关。
Cancer. 2010 Oct 15;116(20):4744-52. doi: 10.1002/cncr.25364.
9
Are Case Volume and Facility Complexity Level Associated With Postoperative Complications After Hip Fracture Surgery in the Veterans Affairs Healthcare System?退伍军人事务部医疗保健系统中，髋关节骨折手术后的术后并发症是否与病例量和医疗机构复杂程度有关？
Clin Orthop Relat Res. 2019 Jan;477(1):177-190. doi: 10.1097/CORR.0000000000000460.
10
Oncological outcomes classified according to metastatic lesions in the era of molecular targeted drugs for metastatic renal cancer.在转移性肾癌分子靶向药物时代，根据转移病灶分类的肿瘤学结局。
Mol Clin Oncol. 2018 Jun;8(6):791-796. doi: 10.3892/mco.2018.1614. Epub 2018 Apr 24.

本文引用的文献

1
Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis.转移性肾细胞癌患者的治疗设施容量与生存：基于登记的分析。
Eur Urol. 2018 Sep;74(3):387-393. doi: 10.1016/j.eururo.2018.05.025. Epub 2018 Jun 5.
2
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.纳武利尤单抗联合伊匹木单抗与舒尼替尼治疗晚期肾细胞癌的比较
N Engl J Med. 2018 Apr 5;378(14):1277-1290. doi: 10.1056/NEJMoa1712126. Epub 2018 Mar 21.
3
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.纳武利尤单抗联合伊匹木单抗治疗晚期黑色素瘤的总生存期
N Engl J Med. 2017 Oct 5;377(14):1345-1356. doi: 10.1056/NEJMoa1709684. Epub 2017 Sep 11.
4
Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study.帕博利珠单抗治疗广泛期小细胞肺癌患者：来自 Ib 期 KEYNOTE-028 研究的结果。
J Clin Oncol. 2017 Dec 1;35(34):3823-3829. doi: 10.1200/JCO.2017.72.5069. Epub 2017 Aug 16.
5
Definitive chemoradiation at high volume facilities is associated with improved survival in glioblastoma.在高容量治疗机构进行确定性放化疗与胶质母细胞瘤患者的生存改善相关。
J Neurooncol. 2017 Oct;135(1):173-181. doi: 10.1007/s11060-017-2563-0. Epub 2017 Jul 7.
6
Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.部分肾切除术与根治性肾切除术治疗 T1b 和 T2 期临床肾肿瘤的比较：系统评价和荟萃分析。
Eur Urol. 2017 Apr;71(4):606-617. doi: 10.1016/j.eururo.2016.08.060. Epub 2016 Sep 7.
7
Impact of facility volume on outcomes in patients with squamous cell carcinoma of the anal canal: Analysis of the National Cancer Data Base.医疗机构容量对肛门管鳞癌患者结局的影响：国家癌症数据库分析。
Cancer. 2017 Jan 1;123(2):228-236. doi: 10.1002/cncr.30327. Epub 2016 Aug 29.
8
Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children.小儿髓母细胞瘤的术后放疗模式及生存意义。
JAMA Oncol. 2016 Dec 1;2(12):1574-1581. doi: 10.1001/jamaoncol.2016.2547.
9
Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer.高容量治疗中心选择行根治性放化疗的 III 期非小细胞肺癌患者的生存获益改善。
J Thorac Oncol. 2015 Jun;10(6):937-43. doi: 10.1097/JTO.0000000000000519.
10
Impact of facility volume on therapy and survival for locally advanced cervical cancer.医疗机构容量对局部晚期宫颈癌治疗和生存的影响。
Gynecol Oncol. 2014 Feb;132(2):416-22. doi: 10.1016/j.ygyno.2013.12.013. Epub 2013 Dec 12.